{"id":478,"date":"2014-07-30T11:15:51","date_gmt":"2014-07-30T09:15:51","guid":{"rendered":"https:\/\/mic-site.labiux.com\/uncategorized\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\/"},"modified":"2026-10-06T06:55:25","modified_gmt":"2026-10-06T03:55:25","slug":"glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11","status":"publish","type":"post","link":"https:\/\/farmacija-mic.lv\/en\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\/","title":{"rendered":"&#8220;GlaxoSmithKline Latvia&#8221; apgroz\u012bjums p\u0113rn samazin\u0101jies par 1%, pe\u013c\u0146a augusi par 11%"},"content":{"rendered":"<div class=\"wp-block-labiux-legacy-html legacy-content\">\n<div class=\"t16\">Farm\u0101cijas uz\u0146\u0113muma SIA &#8220;GlaxoSmithKline Latvia&#8221; (GSK) apgroz\u012bjums p\u0113rn bijis 17,17 miljoni eiro, p\u0113c &#8220;Firmas.lv&#8221; datiem zi\u0146o nacion\u0101l\u0101 inform\u0101cijas a\u0123ent\u016bra LETA. Tas ir par 1% maz\u0101k nek\u0101 2012. gad\u0101, kad apgroz\u012bjums bija 17,4 miljoni eiro. Tikm\u0113r uz\u0146\u0113muma pe\u013c\u0146a p\u0113rn pieaugusi par 11% &#8211; no 677 661 eiro 2012. gad\u0101 l\u012bdz 754 194 eiro 2013. gad\u0101.<\/div>\n<p>Uz\u0146\u0113muma vad\u012bba nor\u0101d\u012bjusi, ka pag\u0101ju\u0161\u0101 gada pe\u013c\u0146a tiks atst\u0101ta nesadal\u012bta, zi\u0146o LETA.<\/p>\n<p>\u0160ogad GSK sagaida apgroz\u012bjuma un pe\u013c\u0146as pieaugumu 1-2% apm\u0113r\u0101. \u0160\u0101da prognoze saist\u012bta ar to, ka nav palielin\u0101ts valsts finans\u0113jums medic\u012bnas nozarei. Neskatoties uz to, GSK prognoz\u0113, ka \u0161ogad uz\u0146\u0113mums stabili turpin\u0101s savu darb\u012bbu.<\/p>\n<p>GSK vad\u012bba uzskata, ka uz\u0146\u0113muma tirgus da\u013ca Latvij\u0101 saglab\u0101sies stabila ar\u012b \u0161ogad un uz\u0146\u0113mums turpin\u0101s sekm\u012bgi un p\u0101rliecino\u0161i darboties, nostiprinot savas poz\u012bcijas Latvijas farm\u0101cijas tirg\u016b un pied\u0101v\u0101jot Latvijas iedz\u012bvot\u0101jiem aizvien jaunus un efekt\u012bvus inovat\u012bvus medikamentus, inform\u0113 LETA.<\/p>\n<p>\n\u00a0<\/p>\n<p>www.farmacija-mic.lv<\/p>\n<p><a href=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/LETA_logo.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-1785 alignleft\" src=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/LETA_logo.jpg\" alt=\"LETA_logo\" width=\"221\" height=\"92\"><\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Farm\u0101cijas uz\u0146\u0113muma SIA &#8220;GlaxoSmithKline Latvia&#8221; (GSK) apgroz\u012bjums p\u0113rn bijis 17,17 miljoni eiro, p\u0113c &#8220;Firmas.lv&#8221; datiem zi\u0146o nacion\u0101l\u0101 inform\u0101cijas a\u0123ent\u016bra LETA. Tas ir par 1% maz\u0101k nek\u0101 2012. gad\u0101, kad apgroz\u012bjums [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":11975,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"mic_cinema_image":0,"mic_focus":"","mic_cinema_focus":"","footnotes":"","_labiux_rail":0},"categories":[70,76],"tags":[],"mic_flag":[],"class_list":["post-478","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-farmacijas-zinas","category-jaunakie-raksti"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"Farm\u0101cijas uz\u0146\u0113muma SIA &quot;GlaxoSmithKline Latvia&quot; (GSK) apgroz\u012bjums p\u0113rn bijis 17,17 miljoni eiro, p\u0113c &quot;Firmas.lv&quot; datiem zi\u0146o nacion\u0101l\u0101 inform\u0101cijas a\u0123ent\u016bra LETA. Tas ir par 1% maz\u0101k nek\u0101 2012. gad\u0101, kad apgroz\u012bjums bija 17,4 miljoni eiro. Tikm\u0113r uz\u0146\u0113muma pe\u013c\u0146a p\u0113rn pieaugusi par 11% - no 677 661 eiro 2012. gad\u0101 l\u012bdz 754 194 eiro 2013. gad\u0101.Uz\u0146\u0113muma vad\u012bba\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/farmacija-mic.lv\/en\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"\u201cGlaxoSmithKline Latvia\u201d apgroz\u012bjums p\u0113rn samazin\u0101jies par 1%, pe\u013c\u0146a augusi par 11% - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:description\" content=\"Farm\u0101cijas uz\u0146\u0113muma SIA &quot;GlaxoSmithKline Latvia&quot; (GSK) apgroz\u012bjums p\u0113rn bijis 17,17 miljoni eiro, p\u0113c &quot;Firmas.lv&quot; datiem zi\u0146o nacion\u0101l\u0101 inform\u0101cijas a\u0123ent\u016bra LETA. Tas ir par 1% maz\u0101k nek\u0101 2012. gad\u0101, kad apgroz\u012bjums bija 17,4 miljoni eiro. Tikm\u0113r uz\u0146\u0113muma pe\u013c\u0146a p\u0113rn pieaugusi par 11% - no 677 661 eiro 2012. gad\u0101 l\u012bdz 754 194 eiro 2013. gad\u0101.Uz\u0146\u0113muma vad\u012bba\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/farmacija-mic.lv\/en\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/euro-coins-2.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/euro-coins-2.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"582\" \/>\n\t\t<meta property=\"og:image:height\" content=\"295\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2014-07-30T09:15:51+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-10-06T03:55:25+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"\u201cGlaxoSmithKline Latvia\u201d apgroz\u012bjums p\u0113rn samazin\u0101jies par 1%, pe\u013c\u0146a augusi par 11% - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Farm\u0101cijas uz\u0146\u0113muma SIA &quot;GlaxoSmithKline Latvia&quot; (GSK) apgroz\u012bjums p\u0113rn bijis 17,17 miljoni eiro, p\u0113c &quot;Firmas.lv&quot; datiem zi\u0146o nacion\u0101l\u0101 inform\u0101cijas a\u0123ent\u016bra LETA. Tas ir par 1% maz\u0101k nek\u0101 2012. gad\u0101, kad apgroz\u012bjums bija 17,4 miljoni eiro. Tikm\u0113r uz\u0146\u0113muma pe\u013c\u0146a p\u0113rn pieaugusi par 11% - no 677 661 eiro 2012. gad\u0101 l\u012bdz 754 194 eiro 2013. gad\u0101.Uz\u0146\u0113muma vad\u012bba\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/euro-coins-2.jpg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/farmacijas-zinas\\\/#listItem\",\"name\":\"Farm\\u0101cija\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/farmacijas-zinas\\\/#listItem\",\"position\":2,\"name\":\"Farm\\u0101cija\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/farmacijas-zinas\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\\\/#listItem\",\"name\":\"&#8220;GlaxoSmithKline Latvia&#8221; apgroz\\u012bjums p\\u0113rn samazin\\u0101jies par 1%, pe\\u013c\\u0146a augusi par 11%\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\\\/#listItem\",\"position\":3,\"name\":\"&#8220;GlaxoSmithKline Latvia&#8221; apgroz\\u012bjums p\\u0113rn samazin\\u0101jies par 1%, pe\\u013c\\u0146a augusi par 11%\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/farmacijas-zinas\\\/#listItem\",\"name\":\"Farm\\u0101cija\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\\\/#newsarticle\",\"name\":\"\\u201cGlaxoSmithKline Latvia\\u201d apgroz\\u012bjums p\\u0113rn samazin\\u0101jies par 1%, pe\\u013c\\u0146a augusi par 11% - Medikamentu Inform\\u0101cijas Centrs\",\"headline\":\"&#8220;GlaxoSmithKline Latvia&#8221; apgroz\\u012bjums p\\u0113rn samazin\\u0101jies par 1%, pe\\u013c\\u0146a augusi par 11%\",\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/euro-coins-2.jpg\",\"width\":582,\"height\":295},\"datePublished\":\"2014-07-30T11:15:51+03:00\",\"dateModified\":\"2026-10-06T06:55:25+03:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\\\/#webpage\"},\"articleSection\":\"Farm\\u0101cija, Jaun\\u0101kie raksti\",\"dateline\":\"Published on July 30, 2014.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\\\/#webpage\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\\\/\",\"name\":\"\\u201cGlaxoSmithKline Latvia\\u201d apgroz\\u012bjums p\\u0113rn samazin\\u0101jies par 1%, pe\\u013c\\u0146a augusi par 11% - Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas uz\\u0146\\u0113muma SIA \\\"GlaxoSmithKline Latvia\\\" (GSK) apgroz\\u012bjums p\\u0113rn bijis 17,17 miljoni eiro, p\\u0113c \\\"Firmas.lv\\\" datiem zi\\u0146o nacion\\u0101l\\u0101 inform\\u0101cijas a\\u0123ent\\u016bra LETA. Tas ir par 1% maz\\u0101k nek\\u0101 2012. gad\\u0101, kad apgroz\\u012bjums bija 17,4 miljoni eiro. Tikm\\u0113r uz\\u0146\\u0113muma pe\\u013c\\u0146a p\\u0113rn pieaugusi par 11% - no 677 661 eiro 2012. gad\\u0101 l\\u012bdz 754 194 eiro 2013. gad\\u0101.Uz\\u0146\\u0113muma vad\\u012bba\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/euro-coins-2.jpg\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\\\/#mainImage\",\"width\":582,\"height\":295},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\\\/#mainImage\"},\"datePublished\":\"2014-07-30T11:15:51+03:00\",\"dateModified\":\"2026-10-06T06:55:25+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"\u201cGlaxoSmithKline Latvia\u201d apgroz\u012bjums p\u0113rn samazin\u0101jies par 1%, pe\u013c\u0146a augusi par 11% - Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas uz\u0146\u0113muma SIA \"GlaxoSmithKline Latvia\" (GSK) apgroz\u012bjums p\u0113rn bijis 17,17 miljoni eiro, p\u0113c \"Firmas.lv\" datiem zi\u0146o nacion\u0101l\u0101 inform\u0101cijas a\u0123ent\u016bra LETA. Tas ir par 1% maz\u0101k nek\u0101 2012. gad\u0101, kad apgroz\u012bjums bija 17,4 miljoni eiro. Tikm\u0113r uz\u0146\u0113muma pe\u013c\u0146a p\u0113rn pieaugusi par 11% - no 677 661 eiro 2012. gad\u0101 l\u012bdz 754 194 eiro 2013. gad\u0101.Uz\u0146\u0113muma vad\u012bba","canonical_url":"https:\/\/farmacija-mic.lv\/en\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/farmacija-mic.lv\/en\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/farmacija-mic.lv\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/#listItem","name":"Farm\u0101cija"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/#listItem","position":2,"name":"Farm\u0101cija","item":"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\/#listItem","name":"&#8220;GlaxoSmithKline Latvia&#8221; apgroz\u012bjums p\u0113rn samazin\u0101jies par 1%, pe\u013c\u0146a augusi par 11%"},"previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\/#listItem","position":3,"name":"&#8220;GlaxoSmithKline Latvia&#8221; apgroz\u012bjums p\u0113rn samazin\u0101jies par 1%, pe\u013c\u0146a augusi par 11%","previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/#listItem","name":"Farm\u0101cija"}}]},{"@type":"NewsArticle","@id":"https:\/\/farmacija-mic.lv\/en\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\/#newsarticle","name":"\u201cGlaxoSmithKline Latvia\u201d apgroz\u012bjums p\u0113rn samazin\u0101jies par 1%, pe\u013c\u0146a augusi par 11% - Medikamentu Inform\u0101cijas Centrs","headline":"&#8220;GlaxoSmithKline Latvia&#8221; apgroz\u012bjums p\u0113rn samazin\u0101jies par 1%, pe\u013c\u0146a augusi par 11%","author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/euro-coins-2.jpg","width":582,"height":295},"datePublished":"2014-07-30T11:15:51+03:00","dateModified":"2026-10-06T06:55:25+03:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\/#webpage"},"isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\/#webpage"},"articleSection":"Farm\u0101cija, Jaun\u0101kie raksti","dateline":"Published on July 30, 2014."},{"@type":"Organization","@id":"https:\/\/farmacija-mic.lv\/en\/#organization","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","url":"https:\/\/farmacija-mic.lv\/en\/"},{"@type":"Person","@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author","url":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/farmacija-mic.lv\/en\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/farmacija-mic.lv\/en\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\/#webpage","url":"https:\/\/farmacija-mic.lv\/en\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\/","name":"\u201cGlaxoSmithKline Latvia\u201d apgroz\u012bjums p\u0113rn samazin\u0101jies par 1%, pe\u013c\u0146a augusi par 11% - Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas uz\u0146\u0113muma SIA \"GlaxoSmithKline Latvia\" (GSK) apgroz\u012bjums p\u0113rn bijis 17,17 miljoni eiro, p\u0113c \"Firmas.lv\" datiem zi\u0146o nacion\u0101l\u0101 inform\u0101cijas a\u0123ent\u016bra LETA. Tas ir par 1% maz\u0101k nek\u0101 2012. gad\u0101, kad apgroz\u012bjums bija 17,4 miljoni eiro. Tikm\u0113r uz\u0146\u0113muma pe\u013c\u0146a p\u0113rn pieaugusi par 11% - no 677 661 eiro 2012. gad\u0101 l\u012bdz 754 194 eiro 2013. gad\u0101.Uz\u0146\u0113muma vad\u012bba","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/#website"},"breadcrumb":{"@id":"https:\/\/farmacija-mic.lv\/en\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\/#breadcrumblist"},"author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"creator":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/euro-coins-2.jpg","@id":"https:\/\/farmacija-mic.lv\/en\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\/#mainImage","width":582,"height":295},"primaryImageOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\/#mainImage"},"datePublished":"2014-07-30T11:15:51+03:00","dateModified":"2026-10-06T06:55:25+03:00"},{"@type":"WebSite","@id":"https:\/\/farmacija-mic.lv\/en\/#website","url":"https:\/\/farmacija-mic.lv\/en\/","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","inLanguage":"en-US","publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Medikamentu Inform\u0101cijas Centrs","og:type":"article","og:title":"\u201cGlaxoSmithKline Latvia\u201d apgroz\u012bjums p\u0113rn samazin\u0101jies par 1%, pe\u013c\u0146a augusi par 11% - Medikamentu Inform\u0101cijas Centrs","og:description":"Farm\u0101cijas uz\u0146\u0113muma SIA &quot;GlaxoSmithKline Latvia&quot; (GSK) apgroz\u012bjums p\u0113rn bijis 17,17 miljoni eiro, p\u0113c &quot;Firmas.lv&quot; datiem zi\u0146o nacion\u0101l\u0101 inform\u0101cijas a\u0123ent\u016bra LETA. Tas ir par 1% maz\u0101k nek\u0101 2012. gad\u0101, kad apgroz\u012bjums bija 17,4 miljoni eiro. Tikm\u0113r uz\u0146\u0113muma pe\u013c\u0146a p\u0113rn pieaugusi par 11% - no 677 661 eiro 2012. gad\u0101 l\u012bdz 754 194 eiro 2013. gad\u0101.Uz\u0146\u0113muma vad\u012bba","og:url":"https:\/\/farmacija-mic.lv\/en\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\/","og:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/euro-coins-2.jpg","og:image:secure_url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/euro-coins-2.jpg","og:image:width":582,"og:image:height":295,"article:published_time":"2014-07-30T09:15:51+00:00","article:modified_time":"2026-10-06T03:55:25+00:00","twitter:card":"summary_large_image","twitter:title":"\u201cGlaxoSmithKline Latvia\u201d apgroz\u012bjums p\u0113rn samazin\u0101jies par 1%, pe\u013c\u0146a augusi par 11% - Medikamentu Inform\u0101cijas Centrs","twitter:description":"Farm\u0101cijas uz\u0146\u0113muma SIA &quot;GlaxoSmithKline Latvia&quot; (GSK) apgroz\u012bjums p\u0113rn bijis 17,17 miljoni eiro, p\u0113c &quot;Firmas.lv&quot; datiem zi\u0146o nacion\u0101l\u0101 inform\u0101cijas a\u0123ent\u016bra LETA. Tas ir par 1% maz\u0101k nek\u0101 2012. gad\u0101, kad apgroz\u012bjums bija 17,4 miljoni eiro. Tikm\u0113r uz\u0146\u0113muma pe\u013c\u0146a p\u0113rn pieaugusi par 11% - no 677 661 eiro 2012. gad\u0101 l\u012bdz 754 194 eiro 2013. gad\u0101.Uz\u0146\u0113muma vad\u012bba","twitter:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/euro-coins-2.jpg"},"aioseo_meta_data":{"post_id":"478","title":null,"description":null,"keywords":null,"keyphrases":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"limit_modified_date":false,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-09-23 01:31:55","updated":"2026-10-07 12:30:15"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/\" title=\"Farm\u0101cija\">Farm\u0101cija<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t\u201cGlaxoSmithKline Latvia\u201d apgroz\u012bjums p\u0113rn samazin\u0101jies par 1%, pe\u013c\u0146a augusi par 11%\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/farmacija-mic.lv\/en\/"},{"label":"Farm\u0101cija","link":"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/"},{"label":"&#8220;GlaxoSmithKline Latvia&#8221; apgroz\u012bjums p\u0113rn samazin\u0101jies par 1%, pe\u013c\u0146a augusi par 11%","link":"https:\/\/farmacija-mic.lv\/en\/glaxosmithkline-latvia-apgrozijums-pern-samazinajies-par-1-pelna-augusi-par-11\/"}],"_links":{"self":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/478","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/comments?post=478"}],"version-history":[{"count":1,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/478\/revisions"}],"predecessor-version":[{"id":2208,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/478\/revisions\/2208"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media\/11975"}],"wp:attachment":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media?parent=478"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/categories?post=478"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/tags?post=478"},{"taxonomy":"mic_flag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/mic_flag?post=478"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}